Ann E. Berman, Director at Immuneering Corp (IMRX), bought 6,000 shares at $6.40 ($38K) on 2022-03-15, disclosed to the SEC on 2022-03-15.
Open-market purchase of $38k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| L | SELL | 2025-09-03 | $275K | — | Filing → |
| L | SELL | 2025-06-03 | $226K | — | Filing → |
| L | SELL | 2025-03-04 | $208K | — | Filing → |